Reuters - A U.S. Senate committee approved on
Wednesday a bill meant to bolster the government's oversight of
prescription drug side effects and extend industry fees that
help speed reviews of new medicines and devices.
Source: http://rss.news.yahoo.com
No comments:
Post a Comment